0.2 g%, and subsequently were sacrificed as follows: five after 1 week PTU-1): five after 2 weeks PTU-2): five after 4 weeks PTU-4): five after 8 weeks PTU-8): five after 12 weeks . In six rats, after 12 weeks of treatment, PTU was withdrawn for 2 months and subsequently started again in three rats which were sacrificed after 2 weeks (PTU-R); the remaining three rats were sacrificed without any further treatment (PTU-R control). Eight rats (control rats) were never treated and served as controls. After sacrifice, blood was drawn for determination of total thyroxine and the thyroid was excised and subdivided into two lobes. Northern analysis for TGF-\g=b\1 was performed in one lobe, while histological and immunohistochemical studies were performed in the other lobe. Gene expression of TGF-\g=b\1 was induced in TSH-and PTU-treated rats. In TSH-treated rats TGF-\g=b\1 gene expression was less detectable than in PTU-treated rats, where it became evident after 2 weeks and remained through weeks 4\p=n-\8. Gene expression of TGF-\g=b\1was also seen in PTU-R rats, but not in the control and in the PTU-R control. Immunohistochemical analysis showed a different presence and location for the TGF-\g=b\1protein, which appears to be dependent on the time of exposure to mitogenic stimulus. In conclusion, TGF-\g=b\1 is produced in response to both a direct (TSH by itself) and indirect (TSH induced by PTU-induced hypothyroidism) cellular proliferative stimulus and is not linked to an adaptative phenomenon secondary to hypothyroidism. The immunohistochemical location of TGF-\g=b\1 within the thyrocytes is influenced by mitogen exposure time. A TGF-\g=b\1 immunohistochemical evaluation may be important to define exposure time and activity of goitrogenic stimuli.
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Forty-three 8-week-old male Wistar rats were studied to evaluate temporal changes of transforming growth factor \g=b\1TGF-\g=b\1) mRNA levels in thyroid tissue during pharmacologically induced goiter. Four rats were treated with purified bovine thyrotropin (TSH; Ambinon, 2 mU/day sc) for 7 days before being sacrificed. Thirty-one were treated with propylthiouracil (PTU), added to their drinking water at a concentration of 0.2 g%, and subsequently were sacrificed as follows: five after 1 week PTU-1): five after 2 weeks PTU-2): five after 4 weeks PTU-4): five after 8 weeks PTU-8): five after 12 weeks (PTU\ x=req-\ 12). In six rats, after 12 weeks of treatment, PTU was withdrawn for 2 months and subsequently started again in three rats which were sacrificed after 2 weeks (PTU-R); the remaining three rats were sacrificed without any further treatment (PTU-R control). Eight rats (control rats) were never treated and served as controls. After sacrifice, blood was drawn for determination of total thyroxine and the thyroid was excised and subdivided into two lobes. Northern analysis for TGF-\g=b\1 was performed in one lobe, while histological and immunohistochemical studies were performed in the other lobe. Gene expression of TGF-\g=b\1 was induced in TSH-and PTU-treated rats. In TSH-treated rats TGF-\g=b\1 gene expression was less detectable than in PTU-treated rats, where it became evident after 2 weeks and remained through weeks 4\p=n-\8. Gene expression of TGF-\g=b\1was also seen in PTU-R rats, but not in the control and in the PTU-R control. Immunohistochemical analysis showed a different presence and location for the TGF-\g=b\1protein, which appears to be dependent on the time of exposure to mitogenic stimulus. In Representative Northern blots of total thyroid RNA hybridized to TGF-/3i and /3-actin are shown in Fig. 2 .
Transforming growth factor ß1 showed a single transcript (2.5kb), scarcely detectable in TSH rats, but which increased in PTU-treated rats from PTU-2 to PTU-12 and also in PTU-R rats. No signal was evident in control rats.
In Fig. 3 , the mean ± sd of AU/mm for each group are shown. Transforming growth factor ß1 protein detected by immunohistochemistry was present in the thyro¬ cytes of treated rats (PTU-1 to PTU-12), in PTU-R and in PTU-R control rats but not in the control rats.
Differences in TGF-/?i protein location within the Fig. 2 . Representative blot of thyroid mRNA hybridized with transforming growth factor ß1 (TGF-ft). The TGF-ft showed a single transcript of 2.5 kb that was scarcely detectable in TSH rats and absent in control rats but was induced in PTU-8 to PTU-12 rats and also in PTU-R rats.
thyrocytes were found. The PTU-1 to PTU-12 rats were protein positive but the controls were not (Fig. 4A) . The TGF-/3] protein follicle positivity increased progressively ( Fig. 4B and 4C ) but began to decline in PTU-12 rats. The TGF-/3j protein location was mainly at the base in PTU-1 to PTU-4 rats but became evident at the apex in PTU-8 and PTU-12 rats (Fig. 4D ).
Discussion
The histological patterns commonly seen in goiter and other abnormalities of thyroid growth reflect the longterm end-result of the disease process. Therefore, the difference in the expression and location of the TGF-/?! protein may correspond to the late consequences of events subsequent to the primary cause.
Pharmacologically induced rat goiter is a useful Fig. 4 
